Gene therapies for cystic fibrosis have previously struggled to reach the faulty lung cells, but a new approach has succeeded in achieving long-lasting modifications in mice
UT Southwestern Medical Center is partnering with Pfizer Inc. to develop RNA-enhanced delivery technologies for genetic medicine therapies through the Dallas-based medical center s Genetic Drug.
As they grow, solid tumors surround themselves with a thick, hard-to-penetrate wall of molecular defenses. Getting drugs past that barricade is notoriously difficult.